Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia

PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: THEISEN,TIMOTHY WAYNE, AMES,ROBERT S, MCMILLAN,LYNETTE JANE, GROSS,MITCHELL STUART, APPELBAUM,EDWARD ROBERT, CHAIKEN,IRWIN M, COOK,RICHARD M, HOLMES,STEPHEN DUDLEY
Format: Patent
Sprache:fin ; swe
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator THEISEN,TIMOTHY WAYNE
AMES,ROBERT S
MCMILLAN,LYNETTE JANE
GROSS,MITCHELL STUART
APPELBAUM,EDWARD ROBERT
CHAIKEN,IRWIN M
COOK,RICHARD M
HOLMES,STEPHEN DUDLEY
description PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FI119374BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FI119374BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FI119374BB3</originalsourceid><addsrcrecordid>eNqFizEOglAMQFkcjHoGewAZCBqjI0YiiZNxJ1Wrlo-_xFYS7sMZvAAXkxh3p_eG94ZBcSAnjxN79GYM2T5chL3iTTyrUYEzKMQcgtRo4Lq2MevejspKWBnhLnwhMyRV_N5rIg8ls1lTc9eCIj_x5fp2HAyuWCpNfhwF03R73OxCqiQnrfBMnixPsyhaxct5ksT_iw-NdkJp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia</title><source>esp@cenet</source><creator>THEISEN,TIMOTHY WAYNE ; AMES,ROBERT S ; MCMILLAN,LYNETTE JANE ; GROSS,MITCHELL STUART ; APPELBAUM,EDWARD ROBERT ; CHAIKEN,IRWIN M ; COOK,RICHARD M ; HOLMES,STEPHEN DUDLEY</creator><creatorcontrib>THEISEN,TIMOTHY WAYNE ; AMES,ROBERT S ; MCMILLAN,LYNETTE JANE ; GROSS,MITCHELL STUART ; APPELBAUM,EDWARD ROBERT ; CHAIKEN,IRWIN M ; COOK,RICHARD M ; HOLMES,STEPHEN DUDLEY</creatorcontrib><description>PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.</description><language>fin ; swe</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20081031&amp;DB=EPODOC&amp;CC=FI&amp;NR=119374B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20081031&amp;DB=EPODOC&amp;CC=FI&amp;NR=119374B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>THEISEN,TIMOTHY WAYNE</creatorcontrib><creatorcontrib>AMES,ROBERT S</creatorcontrib><creatorcontrib>MCMILLAN,LYNETTE JANE</creatorcontrib><creatorcontrib>GROSS,MITCHELL STUART</creatorcontrib><creatorcontrib>APPELBAUM,EDWARD ROBERT</creatorcontrib><creatorcontrib>CHAIKEN,IRWIN M</creatorcontrib><creatorcontrib>COOK,RICHARD M</creatorcontrib><creatorcontrib>HOLMES,STEPHEN DUDLEY</creatorcontrib><title>Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia</title><description>PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFizEOglAMQFkcjHoGewAZCBqjI0YiiZNxJ1Wrlo-_xFYS7sMZvAAXkxh3p_eG94ZBcSAnjxN79GYM2T5chL3iTTyrUYEzKMQcgtRo4Lq2MevejspKWBnhLnwhMyRV_N5rIg8ls1lTc9eCIj_x5fp2HAyuWCpNfhwF03R73OxCqiQnrfBMnixPsyhaxct5ksT_iw-NdkJp</recordid><startdate>20081031</startdate><enddate>20081031</enddate><creator>THEISEN,TIMOTHY WAYNE</creator><creator>AMES,ROBERT S</creator><creator>MCMILLAN,LYNETTE JANE</creator><creator>GROSS,MITCHELL STUART</creator><creator>APPELBAUM,EDWARD ROBERT</creator><creator>CHAIKEN,IRWIN M</creator><creator>COOK,RICHARD M</creator><creator>HOLMES,STEPHEN DUDLEY</creator><scope>EVB</scope></search><sort><creationdate>20081031</creationdate><title>Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia</title><author>THEISEN,TIMOTHY WAYNE ; AMES,ROBERT S ; MCMILLAN,LYNETTE JANE ; GROSS,MITCHELL STUART ; APPELBAUM,EDWARD ROBERT ; CHAIKEN,IRWIN M ; COOK,RICHARD M ; HOLMES,STEPHEN DUDLEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FI119374BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fin ; swe</language><creationdate>2008</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>THEISEN,TIMOTHY WAYNE</creatorcontrib><creatorcontrib>AMES,ROBERT S</creatorcontrib><creatorcontrib>MCMILLAN,LYNETTE JANE</creatorcontrib><creatorcontrib>GROSS,MITCHELL STUART</creatorcontrib><creatorcontrib>APPELBAUM,EDWARD ROBERT</creatorcontrib><creatorcontrib>CHAIKEN,IRWIN M</creatorcontrib><creatorcontrib>COOK,RICHARD M</creatorcontrib><creatorcontrib>HOLMES,STEPHEN DUDLEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>THEISEN,TIMOTHY WAYNE</au><au>AMES,ROBERT S</au><au>MCMILLAN,LYNETTE JANE</au><au>GROSS,MITCHELL STUART</au><au>APPELBAUM,EDWARD ROBERT</au><au>CHAIKEN,IRWIN M</au><au>COOK,RICHARD M</au><au>HOLMES,STEPHEN DUDLEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia</title><date>2008-10-31</date><risdate>2008</risdate><abstract>PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fin ; swe
recordid cdi_epo_espacenet_FI119374BB
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
title Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A48%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=THEISEN,TIMOTHY%20WAYNE&rft.date=2008-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFI119374BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true